DOCSLIB.ORG
  • Sign Up
  • Log In
  • Upload
  • Sign Up
  • Log In
  • Upload
  • Home
  • »  Tags
  • »  Secnidazole

Secnidazole

  • The National Drugs List

    The National Drugs List

  • Agenda

    Agenda

  • Nitroaromatic Antibiotics As Nitrogen Oxide Sources

    Nitroaromatic Antibiotics As Nitrogen Oxide Sources

  • Secnidazole (Solosec) Reference Number: CP.PMN.103 Effective Date: 03.01.18 Last Review Date: 02.20 Line of Business: Commercial, HIM, Medicaid Revision Log

    Secnidazole (Solosec) Reference Number: CP.PMN.103 Effective Date: 03.01.18 Last Review Date: 02.20 Line of Business: Commercial, HIM, Medicaid Revision Log

  • 204684Orig1s000

    204684Orig1s000

  • (12) Patent Application Publication (10) Pub. No.: US 2011/0159073 A1 De Juan Et Al

    (12) Patent Application Publication (10) Pub. No.: US 2011/0159073 A1 De Juan Et Al

  • Antiparasitic Treatments in Pregnant Women: Update and Recommendations E Boitel, Guillaume Desoubeaux

    Antiparasitic Treatments in Pregnant Women: Update and Recommendations E Boitel, Guillaume Desoubeaux

  • 71 Antiprotozoal Chemotherapy

    71 Antiprotozoal Chemotherapy

  • Secnidazole in the Treatment of Giardiasis

    Secnidazole in the Treatment of Giardiasis

  • Parasitic Infections (1 of 14)

    Parasitic Infections (1 of 14)

  • Cryptosporidium Cystoisospora Belli Cyclospora Cayetanensis © by Author

    Cryptosporidium Cystoisospora Belli Cyclospora Cayetanensis © by Author

  • Final1-Aritmo-Final-Report-V2-0Final.Pdf

    Final1-Aritmo-Final-Report-V2-0Final.Pdf

  • Common Study Protocol for Observational Database Studies WP5 – Analytic Database Studies

    Common Study Protocol for Observational Database Studies WP5 – Analytic Database Studies

  • MED-SEP 392-403 NUEVOS.Indd

    MED-SEP 392-403 NUEVOS.Indd

  • SOLOSEC (Secnidazole) Oral Granules Require Treatment with an Antifungal Agent

    SOLOSEC (Secnidazole) Oral Granules Require Treatment with an Antifungal Agent

  • 209363Orig1s000

    209363Orig1s000

  • Point Prevalence Survey of Healthcare-Associated Infections and Antimicrobial Use in European Acute Care Hospitals

    Point Prevalence Survey of Healthcare-Associated Infections and Antimicrobial Use in European Acute Care Hospitals

  • Comparative in Vitro Resistance of Human Periodontal Bacterial Pathogens to Tinidazole and Four Other Antibiotics

    Comparative in Vitro Resistance of Human Periodontal Bacterial Pathogens to Tinidazole and Four Other Antibiotics

Top View
  • Application of Thin Layer Chromatography in Analysis of Secnidazole, Ornidazole, Tinidazole and Nimorazole
  • Guidelines for the Prevention and Treatment of Opportunistic Infections in HIV-Exposed and HIV-Infected Children
  • Amoebic Dysentery Search Date July 2006 Leonila Dans and Elizabeth Martínez
  • Clinical Trial with Secnidazole in a Single Dose in Venezuelan Children Infected by Giardia Intestinalis
  • WHO Drug Information Vol. 11, No. 3, 1997
  • Paromomycin Is Superior to Metronidazole in Dientamoeba Fragilis Treatment T Ander Burgañaa, Rosa Abellanab, Stanislav Zlatanov Yordanova, Rabee Kazana, A
  • FEP 5 Tier Rx Drug Formulary (607) Standard Option
  • Chemical Structure-Related Drug-Like Criteria of Global Approved Drugs
  • Compositions Comprising a Mucoadhesive Protein and an Active Principle for Mucosal Delivery of Said Agent
  • Chemotherapy of Amoebiasis and Giardiasis
  • A Comparative Study of Oral Single Dose of Metronidazole, Tinidazole, Secnidazole and Ornidazole in Bacterial Vaginosis
  • Antibiotics, Gastrointestinal Therapeutic Class Review (TCR)
  • Treatment Guidelines for Antimicrobial Use in Common Syndromes
  • Antiamoebic Drugs
  • (12) United States Patent (10) Patent No.: US 8,414.914 B2 Bromley Et Al
  • Current Treatment Options for Dientamoeba Fragilis Infections ⇑ Noriyuki Nagata A,B, Deborah Marriott A,B, John Harkness A,B, John T
  • Australian Statistics on Medicines 2009
  • Antimicrobial Resistance Benchmark 2018


© 2024 Docslib.org    Feedback